Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.43−0.06 (-2.41%)
Close on Nov 13, 2026Market cap $359.12MP/E –Yield –
Tilray Brands cash
Cash and short-term investments held at the end of each period.
Tilray Brands's cash was $218.01M at Aug 31, 2026. For fiscal 2026 it was $231.27M, down 9.8% from the year before. The highest annual figure on record is $517.59M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $231.27M | -9.8% |
| FY2025 | May 31, 2025 | $256.36M | -1.6% |
| FY2024 | May 31, 2024 | $260.52M | -41.9% |
| FY2023 | May 31, 2023 | $448.53M | +7.8% |
| FY2022 | May 31, 2022 | $415.91M | +329.7% |
| FY2019 | Dec 31, 2019 | $96.79M | -81.3% |
| FY2018 | Dec 31, 2018 | $517.59M | +22181.1% |
| FY2017 | Dec 31, 2017 | $2.32M | -69.2% |
| FY2016 | Dec 31, 2016 | $7.53M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $218.01M | -17.7% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $231.27M | -9.8% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $219.93M | -12.8% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $291.55M | +4.1% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $264.83M | +1.7% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $256.36M | +13.5% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $252.25M | -2.9% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $280.06M | -39.8% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $260.52M | -41.9% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $225.86M | -44.7% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $259.79M | -40.1% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $464.85M | -5.3% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $448.53M | +7.8% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $408.28M | +46.2% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $433.50M | +30.7% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $490.64M | +30.4% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $415.91M | +329.7% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $279.21M | +128.2% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $331.78M | +50.2% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $376.30M | +15.6% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $96.79M | -81.3% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $122.37M | +2.9% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $220.87M | +772.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $325.43M | +13909.2% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $517.59M | +6968.0% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $118.96M | +1479.6% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $25.33M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $2.32M | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $7.32M | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | $7.53M | – |
See a number that looks wrong?